The Los Angeles Stroke Rehab Network

LASER-Net Leadership

	Steven C. Cramer, MD Dr. Steven C. Cramer is a Professor of Neurology at the University of California, Los Angeles, where he holds the Susan and David Wilstein Endowed Chair in Rehabilitation Medicine. He is also the Director of Research at California Rehabilitation Institute, co-PI of the NIH StrokeNet clinical trials network, Associate Editor at Neurorehabilitation and Neural Repair, and a Section Editor at the journal Stroke. Dr. Cramer graduated with Highest Honors from University of California, Berkeley; received his medical degree from University of Southern California; did a residency in internal medicine at UCLA; and did a residency in neurology plus a fellowship in cerebrovascular disease at Massachusetts General Hospital. He also earned a Masters Degree in Clinical Investigation from Harvard Medical School. His research focuses on neural repair after central nervous system injury in humans, with an emphasis on stroke and on recovery of movement.

	Eden Farahmand Eden is a fourth-year undergraduate student at UCLA majoring in Physiological Science. He has been a member of Dr. Cramer's stroke laboratory since 2022 and is assisting in organizing events for LASER-Net, fostering collaboration and knowledge exchange among patients, scientists, and clinicians. His research interests include stroke pathophysiology, brain-computer interfaces, and neural plasticity. This year, he is applying to medical school to pursue his dream of becoming a physician.

	Shivani Sakthi Shivani is a fourth-year undergraduate in UCLA with a major in Physiological Science and a minor in Community Engagement & Social Change. She has been a member of Dr. Cramer's stroke neurology lab since 2022. In her fourth year, she is assisting Dr. Cramer in organizing LASER-Net events while applying to medical school. In addition to her interest in clinical research, Shivani aims to prioritize community health and improve healthcare accessibility in her future medical career. She is interested in the intersections between research and development frameworks and treatment costs.